SoyMeds is a biotechnology research company focused on the development and validation of soybean seed-based therapeutics that can be used to treat, prevent, cure, and diagnose disease. Today there is a high demand to produce safe, stable, and cost effective therapeutics. A soybean seed-derived vaccine will address many of the challenges associated with conventional vaccine production and distribution (storage, cold chain, high production costs, purification, etc.) while toleragens will provide a therapy for treating and potentially curing autoimmune disease. SoyMedsâ diagnostics will allow for significant cost reduction of analytes, production of analytes that are not commercially available, increased sensitivity and quantification of diagnostic markers, and the development of novel medical devices based on these analytes.
